Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...
New technologies, cancer doctors, and reproductive specialists are working to give more patients a chance to have children post-treatment.
Young adults’ use of vapes and cannabis hit all-time highs last year, according to the results of a large new national survey conducted at the University of Michigan. The percentage of young adults ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
For this monthslong investigation, Casey and Brittany obtained and reviewed internal company communications, legal filings, and customer contracts; they also talked to over three dozen ex-employees, ...
The White House's order attempting to overhaul the vaccine schedule could subject children to more needles and more disease risk, world health leaders say.
Talks are underway between the Democratic Republic of the Congo and the WHO to expedite the start of a multi-armed Phase 3 clinical trial of Ebola vaccines.
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...
A highly anticipated No Surprises Act court decision delivered yet another win for providers, finding that the government erred in its instructions for calculating the amounts health insurers ...
The Trump administration on Wednesday unveiled a new framework for helping Americans facing the often-intertwined circumstances of addiction and homelessness. In a new toolkit, th ...
Our understanding and treatment of postpartum psychiatric illnesses remain profoundly inadequate,” experts write.
Waiting for treatment to start can be an excruciating period for cancer patients. There can be fears that the disease is spreading, or progressing to a point where therapies becom ...